program｜The 93rd Annual Meeting of the Japanese Pharmacological Society

March 16 (Mon) Room I

Symposium7

Shedding light on brain functions and novel therapeutic strategies by multi-scale calcium signal analysis

1-S07-19:0010:30 Double-Nanodomain Coupling of P/Q-type Ca²⁺ Channels, Ryanodine Receptors, and BK Channels Controls the Generation of Burst Firing Tomohiko Irie Div. Pharm., National Institute of Health Sciences

1-S07-29:0010:30 Multiscale Ca²⁺ imaging for brain function analysis Makoto Osanai^1,2 ¹Dept. Medical Phys. Eng., Div. Health Sci., Osaka Univ. Grad. Sch. Med., ²Dept. Neurophysiol., Tohoku Univ. Grad. Sch. Med.

1-S07-39:0010:30 Regulation of calcium signal pathway in fear-related memory Shigeki Moriguchi¹, Satomi Kita², Takahiro Iwamoto³, Kohl Fukunaga¹ ¹Dept. Pharmacol., Grad. Sch. Pharmaceut. Sci., Tohoku Univ., ²Dept. Pharmacol., Fac. Pharmaceut. Sci., Tokushima Bunri Univ., ³Dept. Pharmacol., Fac. Med. Fukuoka Univ.

1-S07-49:0010:30 Involvement of Redox Modification of Ca²⁺-Release Channels in Cerebellar Learning and Aging Sho Kakizawa Dept. Biol. Chem., Gra. Sch. Pharmaceu. Sci., Kyoto Univ.

Symposium14

Frontiers in Ca²⁺-induced Ca²⁺ release (CICR) research: Commemorating the 50th anniversary of CICR discovery

1-S14-110:3012:00 Our serendipitous encounter with CICR Makoto Endo Dept. Pharmacol., Univ. of Tokyo

1-S14-210:3012:00 Analysis of CICR control mechanism using molecular dynamics simulation and malignant hyperthermia model mouse Toshiko Yamazawa Dept. Physiol., Jikei Univ. Sch. Med.

1-S14-310:3012:00 Abnormal RyR2 in arrhythmogenic disorders and CICR Nagomi Kurebayashi Dept. Pharmacol., Juntendo Univ. Sch. Med.

1-S14-410:3012:00 Structural insight of Ca²⁺induced Ca²⁺release mechanism revealed by cryo-EM Haruo Ogawa IQB, The University of Tokyo

Symposium17

Novel pharmacological approaches in search of therapeutic targets for psychiatric and neurological disorders: Challenges and opportunities

1-S17-114:2016:20 Optogenetic examination of effects of stress on the orbitofrontal-amygdala synaptic transmission Hiroshi Kuniishi^1,2, Masayuki Sekiguchi², Mitsuhiko Yamada¹ ¹Dept Neuropsychopharmacoly, National Institute of Mental Health, National Center of Neurology and Psychiatry, ²Dept Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry

1-S17-214:2016:20 Mechanism of axonal degeneration: from molecular signaling to the development of therapeutic applications Toshiyuki Araki, Shuji Wakatsuki Dept PNS Res, Natl Inst Neurosci, Natl Ctr Neurol Psych (NCNP)

1-S17-314:2016:20 Novel defense strategy against progressive neurodegeneration by controlling intracellular Zn²⁺dysregulation Atsushi Takeda Dept. Neurophysiology, Sch. Pharmaceutical Sciences, Univ. Shizuoka

1-S17-414:2016:20 Therapeutic strategy for Parkinson's disease: Targeting zinc-binding protein in astrocytes Ikuko Miyazaki, Masato Asanuma Dept. of Medical Neurobiology, Okayama Univ. Grad. Sch. of Med., Dent. and Pharmaceut. Sci.

1-S17-514:2016:20 Neuroimmune system associated with brain development and neurodevelopmental disorders Shogo Tanabe, Rieko Muramatsu Dept. Mol. Pharm., Natl. Inst. Neurosci., Natl Center of Neurology and Psychiatry

pagetop